Skip to Content
Merck
CN

HPLC Analysis of 3-Methylpyrazole and 4-Methylpyrazole in Urine on Discovery® C18 after SPE using Discovery® DSC-SCX

HPLC Analysis of 3-Methylpyrazole and 4-Methylpyrazole in Urine on Discovery® C18 after SPE using Discovery® DSC-SCX application for SPE, application for HPLC

Materials

analytical column

Product No.
Description
Pricing

Discovery® C18 HPLC Column

5 μm particle size, L × I.D. 15 cm × 4.6 mm

related product

Product No.
Description
Pricing

Discovery® DSC-SCX SPE Tube

bed wt. 500 mg, volume 3 mL, pk of 54

CONDITIONS

sample preparation

SPE (Solid Phase Extraction)

sample/matrix

urine spiked with 3- and 4-methylpyrazole at 1 mg/mL

SPE tube/cartridge

Discovery DSC-SCX, 500 mg/3 mL (52686-U)

condition

2 mL methanol; 2 mL DI water

sample addition

1 mL

washing

2 mL DI water

elution

2 mL 5% methanol in 250 mM potassium phosphate buffer, pH 7.4

column

Discovery C18, 15 cm × 4.6 mm, 5 μm preceded by a 2 cm guard column and 0.5 μm frit filter (504955)

mobile phase

MeOH:5 mM phosphate buffer, pH 6 (20:80)

flow rate

1 mL/min

column temp.

30 °C

detector

UV, 220 nm

injection

25 μL, dilute urine extract

Description

Legal Information

Discovery is a registered trademark of Merck KGaA, Darmstadt, Germany